Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
J Immunother Cancer. 2023 Oct;11(10):e007288. doi: 10.1136/jitc-2023-007288.
J Immunother Cancer. 2023.
PMID: 37802604
Free PMC article.
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo.
Bunch BL, Morse J, Asby S, Blauvelt J, Aydin AM, Innamarato P, Hajiran A, Beatty M, Poch M, Pilon-Thomas S.
Bunch BL, et al. Among authors: blauvelt j.
J Immunother Cancer. 2020 Dec;8(2):e001673. doi: 10.1136/jitc-2020-001673.
J Immunother Cancer. 2020.
PMID: 33303579
Free PMC article.
Item in Clipboard
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
Hall MS, Mullinax JE, Cox CA, Hall AM, Beatty MS, Blauvelt J, Innamarato P, Nagle L, Branthoover H, Wiener D, Schachner B, Martinez AJ, Richards AD, Rich CJ, Colón Colón M, Schell MJ, Teer JK, Khushalani NI, Weber JS, Mulé JJ, Sondak VK, Pilon-Thomas S, Sarnaik AA.
Hall MS, et al. Among authors: blauvelt j.
Clin Cancer Res. 2022 Dec 15;28(24):5317-5329. doi: 10.1158/1078-0432.CCR-22-2103.
Clin Cancer Res. 2022.
PMID: 36215121
Free PMC article.
Clinical Trial.
Item in Clipboard
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors.
Innamarato P, Morse J, Mackay A, Asby S, Beatty M, Blauvelt J, Kidd S, Mullinax JE, Sarnaik AA, Pilon-Thomas S.
Innamarato P, et al. Among authors: blauvelt j.
BMC Cancer. 2021 Jun 30;21(1):756. doi: 10.1186/s12885-021-08522-z.
BMC Cancer. 2021.
PMID: 34187428
Free PMC article.
Item in Clipboard
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
Bazargan S, Bunch B, Ojwang' AME, Blauvelt J, Landin A, Ali J, Abrahams D, Cox C, Hall AM, Beatty MS, Poch M, Rejniak KA, Pilon-Thomas S.
Bazargan S, et al. Among authors: blauvelt j.
Front Immunol. 2023 Oct 12;14:1275375. doi: 10.3389/fimmu.2023.1275375. eCollection 2023.
Front Immunol. 2023.
PMID: 37901214
Free PMC article.
Item in Clipboard
Cite
Cite